A client who has chronic bronchial asthma has had a mast cell stabilizer prescribed.
What drug would the provider prescribe?
Isoetharine.
Aminophylline.
Ipratropium.
Cromolyn.
The Correct Answer is D
Choice A. Isoetharine is a bronchodilator that works by relaxing muscles in the airways to improve breathing. It is not a mast cell stabilizer.
Choice B is wrong because aminophylline is a bronchodilator that relaxes the muscles in the airways and is used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). It is not a mast cell stabilizer.
Choice C is wrong because Ipratropium is an anticholinergic bronchodilator that helps to open up the airways in the lungs. It is used in the treatment of COPD and sometimes asthma, but it is not a mast cell stabilizer.
Choice D. Cromolyn is a mast cell stabilizer that helps prevent the release of substances in the body that cause inflammation and asthma symptoms. It is used for the prevention of asthma attacks and is particularly effective in managing exercise-induced asthma and allergic asthma triggers.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
This is because prednisolone can cause insomnia if taken later in the day, and it mimics the natural secretion of cortisol by the adrenal glands, which peaks in the morning.
Choice A is wrong because splitting the dose into two equal doses can increase the risk of adrenal suppression and reduce the efficacy of alternate-day therapy (ADT), which is used to minimize adverse effects of corticosteroids.
Choice B is wrong because taking prednisolone before bedtime can interfere with sleep and cause nocturnal cortisol secretion, which can lead to Cushing syndrome.
Choice C is wrong because taking prednisolone 1 hour before meals can cause gastric irritation and ulceration, and it is recommended to take it with food or milk.
Correct Answer is D
Explanation
Famotidine is a histamine type 2 receptor antagonist (H blocker) which is commonly used for treatment of acid-peptic disease and heartburn. Famotidine has been linked to rare instances of clinically apparent acute liver injury, but it is less likely to cause hepatotoxicity than cimetidine, another H blocker. Famotidine also has fewer drug interactions than cimetidine.
Choice A is wrong because nizatidine is another H blocker that can cause mild and transient serum aminotransferase elevations.
Nizatidine has not been linked to cases of clinically apparent liver injury, but it has not been widely used.
Choice B is wrong because ranitidine is another H blocker that can cause mild and transient serum aminotransferase elevations.
Ranitidine has also been associated with rare instances of clinically apparent liver injury, some of which were fatal or required liver transplantation.
Choice C is wrong because cimetidine is another H blocker that can cause mild and transient serum aminotransferase elevations.
Cimetidine has also been implicated in several cases of clinically apparent acute liver injury, some of which were severe and led to acute liver failure and death.
Cimetidine also has many drug interactions due to its inhibition of cytochrome P enzymes.
Normal ranges for serum aminotransferases are 7 to 56 U/L for alanine aminotransferase (ALT) and 10 to 40 U/L for as
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today